Ellen M. Zane - Feb 24, 2025 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
Director
Signature
/s/ Susan Thompson, Attorney-in-Fact
Stock symbol
BSX
Transactions as of
Feb 24, 2025
Transactions value $
-$1,416,134
Form type
4
Date filed
2/24/2025, 04:08 PM
Previous filing
Feb 20, 2025
Next filing
Apr 2, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Sale -$1.42M -13.6K -28% $104.23 34.9K Feb 24, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 14, 2024.
F2 Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $103.88 to $104.545, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.